167 related articles for article (PubMed ID: 38055645)
1. Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer.
Athavale D; Barahona I; Song Z; Desert R; Chen W; Han H; Das S; Ge X; Komakula SSB; Gao S; Lantvit D; Guzman G; Nieto N
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055645
[TBL] [Abstract][Full Text] [Related]
2. Transformation of SOX9
Chen J; Debebe A; Zeng N; Kopp J; He L; Sander M; Stiles BL
Sci Rep; 2021 Jun; 11(1):11823. PubMed ID: 34083580
[TBL] [Abstract][Full Text] [Related]
3. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
[TBL] [Abstract][Full Text] [Related]
4. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
Sia D; Villanueva A; Friedman SL; Llovet JM
Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
[TBL] [Abstract][Full Text] [Related]
5. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
6. Ablation of high-mobility group box-1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling-deficient mice.
Athavale D; Song Z; Desert R; Han H; Das S; Ge X; Komakula SSB; Chen W; Gao S; Lantvit D; Guzman G; Nieto N
Hepatol Commun; 2022 Aug; 6(8):2155-2169. PubMed ID: 35344292
[TBL] [Abstract][Full Text] [Related]
7. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Casalino A; Bocca C; Novo E; Protopapa F; Ramavath NN; Provera A; Gambella A; Bugianesi E; Tacke F; Albano E; Parola M
Front Immunol; 2024; 15():1342404. PubMed ID: 38469298
[TBL] [Abstract][Full Text] [Related]
8. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
[TBL] [Abstract][Full Text] [Related]
9. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
[TBL] [Abstract][Full Text] [Related]
10. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
[TBL] [Abstract][Full Text] [Related]
11.
Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.
Hernandez C; Huebener P; Pradere JP; Antoine DJ; Friedman RA; Schwabe RF
J Clin Invest; 2018 Jun; 128(6):2436-2451. PubMed ID: 29558367
[TBL] [Abstract][Full Text] [Related]
13. Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.
Kato T; Murata D; Anders RA; Sesaki H; Iijima M
Biochem Biophys Res Commun; 2021 Apr; 549():83-90. PubMed ID: 33667713
[TBL] [Abstract][Full Text] [Related]
14. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
15. CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression.
Yang B; Zhang J; Wang J; Fan W; Barbier-Torres L; Yang X; Justo MAR; Liu T; Chen Y; Steggerda J; Ramani K; Lu SC; Yang H
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37347224
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
17. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
[TBL] [Abstract][Full Text] [Related]
18. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.
Xu X; Kobayashi S; Qiao W; Li C; Xiao C; Radaeva S; Stiles B; Wang RH; Ohara N; Yoshino T; LeRoith D; Torbenson MS; Gores GJ; Wu H; Gao B; Deng CX
J Clin Invest; 2006 Jul; 116(7):1843-52. PubMed ID: 16767220
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
Chen Y; Lin C; Liu Y; Jiang Y
Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 can be used to monitor perioperative course in patients with liver cancer.
Satoh M; Taira K; Hara T; Siba J; Takeuchi M
Surg Oncol; 2020 Jun; 33():216-221. PubMed ID: 31443921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
